Status:
UNKNOWN
Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction
Lead Sponsor:
Ullevaal University Hospital
Collaborating Sponsors:
Helse Innlandet
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
In the district areas of Norway patients with acute myocardial infarction with ST-elevation, are treated with thrombolysis. An increasing part of them receives thrombolysis before arrival to the local...
Eligibility Criteria
Inclusion
- Duration of painless than 6 hours.
- ST-segment elevation of at least 0.1 mV in two or more extremity leads or at least 0.2 mV in two or more precordial leads.
- The patient is getting thrombolysis.
- Time to reach an invasive center is more than 1 hour.
- Age 18-75 years.
Exclusion
- Known serious renal failure (creatinin \> 250 mmol/l)
- Pregnancy
- Cardiogenic chock
- Life threatening arrythmias
- Other serious diseases with life expectancy less than 1 year.
- Inability to perform an informed consent
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT00161005
Start Date
February 1 2005
End Date
December 1 2009
Last Update
April 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulleval University Hospital
Oslo, Norway, 0407